| Bioactivity | Indobufen sodium is a platelet aggregation inhibitor. Indobufen sodium is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen sodium suppresses thromboxane A2 (TxA2) synthesis. Indobufen sodium down-regulates tissue factor (TF) in monocytes[1]. |
| CAS | 94135-04-3 |
| Formula | C18H16NNaO3 |
| Molar Mass | 317.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eligini S, et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. Cardiovasc Res. 2006 Jan;69(1):218-26. |
Indobufen sodium
CAS: 94135-04-3 F: C18H16NNaO3 W: 317.31
Indobufen sodium is a platelet aggregation inhibitor. Indobufen sodium is a reversible platelet cyclooxygenase (Cox) act
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.